Navigating the complexities of pharmaceutical trademarks

What is the webinar about?

Clearing and protecting pharmaceutical trademarks presents a host of challenges unique to this industry. Minimizing the risk of brand confusion isn’t just a matter of consumer convenience—it is critical for protecting patient safety. In this webinar, two experienced trademark practitioners examine the complexities of the pharma trademark process and how trademark professionals can minimize the risk of rejection.

Topics Include:

  • Product and trademark development cycles unique to pharmaceuticals 
  • The multi-layered clearance process and the differing perspectives of the trademark office and regulatory agencies
  • The "inverted pyramid" naming process for pharma brands
  • Strategies for trademark research and assessing search results
  • Tips for aligning stakeholders—from R&D and marketing to legal and regulatory


Maury M. Tepper, III
Co-founder and Principal
Tepper & Eyster

Maury Tepper is a respected practitioner of intellectual property law and board certified specialist in trademark law, with particular experience serving pharmaceutical clients. He has served on the Trademark Public Advisory Committee to the U.S. Patent and Trademark Office, and served as Counsel to INTA.

Emmanuelle Ragon
Senior Legal Director, Head of Trade Marks

Emmanuelle Ragon joined Sanofi in 2001. Since 2008, she has led the trademarks, domain names, and copyright team with the goal to build efficient strategies for the selection, protection and enforcement of healthcare trademarks. Before Sanofi, she started her career in a dairy food company.

Event details

  • Date Thursday, August 1, 2019
  • Time 10:00 AM Eastern Daylight Time (New York, GMT-04:00)
    9:00 AM Central Daylight Time (Chicago, GMT-05:00)
    7:00 AM Pacific Daylight Time (San Francisco, GMT-07:00)
    3:00 PM GMT Summer Time (London, GMT+01:00)
  • Duration 1 hour